K.J. Harrison & Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

K.J. Harrison & Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Sell	1,720 -30,160	-95%	-$3.77M	0.04%	216
2025 Q4	$3.89M	Buy	31,880 +10,080	+46%	+$1.16M	0.52%	57
2025 Q3	$2.24M	Buy	21,800 +16,000	+276%	+$1.44M	0.32%	86
2025 Q2	$481K	Hold	5,800	–	–	0.08%	155
2025 Q1	$470K	Sell	5,800 -18,000	-76%	-$1.61M	0.09%	140
2024 Q4	$2.18M	Buy	23,800 +2,000	+9%	+$194K	0.34%	77
2024 Q3	$2.14M	Buy	21,800 +800	+4%	+$78.6K	0.32%	83
2024 Q2	$1.95M	Buy	21,000 +5,200	+33%	+$466K	0.32%	81
2024 Q1	$1.5M	Sell	15,800 -5,012	-24%	-$465K	0.23%	104
2023 Q4	$1.86M	Buy	+20,812	New	+$1.55M	0.32%	87
2023 Q3	–	Sell	-5,800	Closed	-$481K	–	211
2023 Q2	$481K	Hold	5,800	–	–	0.09%	164
2023 Q1	$442K	Sell	5,800 -11,000	-65%	-$913K	0.09%	165
2022 Q4	$1.89M	Buy	+16,800	New	+$1.36M	0.37%	88
2022 Q3	–	Sell	-33,200	Closed	-$2.47M	–	244
2022 Q2	$2.47M	Buy	33,200 +24,400	+277%	+$1.83M	0.67%	45
2022 Q1	$791K	Buy	8,800 +900	+11%	+$83.1K	0.13%	141
2021 Q4	$886K	Buy	+7,900	New	+$953K	0.13%	170
2021 Q3	–	Sell	-4,000	Closed	-$542	–	414
2021 Q2	$542	Sell	4,000 -5,000	-56%	-$657K	0.06%	201
2021 Q1	$1.22M	Hold	9,000	–	–	0.19%	134
2020 Q4	$1.27M	Sell	9,000 -7,000	-44%	-$897K	0.21%	139
2020 Q3	$1.78M	Sell	16,000 -11,000	-41%	-$1.23M	0.37%	91
2020 Q2	$3.02M	Buy	+27,000	New	+$2.66M	0.83%	40

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

K.J. Harrison & Partners's XBI Position: Q1 2026 in Review

K.J. Harrison & Partners reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 95% in Q1 2026, selling an estimated $3.77M and leaving 1,720 shares worth $220K. The position accounts for 0.04% of the portfolio, ranked #216.

K.J. Harrison & Partners first reported a position in XBI in Q2 2020 and has held it in 21 quarters since. The position peaked at $3.89M in Q4 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

K.J. Harrison & Partners held 1,720 shares of State Street SPDR S&P Biotech ETF worth $220K as of Q1 2026.
K.J. Harrison & Partners sold 30,160 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $3.77M.
State Street SPDR S&P Biotech ETF made up 0.04% of K.J. Harrison & Partners's portfolio in Q1 2026, its #216 holding.
K.J. Harrison & Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 21 quarters since.
K.J. Harrison & Partners's State Street SPDR S&P Biotech ETF position peaked at $3.89M in Q4 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.